Core Viewpoint - Eos Energy Enterprises, Inc. is under investigation for potential violations of federal securities laws, particularly concerning misleading statements about its revenue growth and manufacturing capabilities [1][3]. Company Overview - Eos manufactures zinc-based long-duration battery energy storage systems aimed at storing renewable energy and enhancing grid reliability [2]. Investigation Details - The investigation focuses on whether Eos made false and misleading statements regarding its near-term revenue growth and the execution of its manufacturing efforts [3][9]. Financial Performance - Eos reported a significant net loss of approximately $970 million for fiscal year 2025, with revenue falling short of previously reaffirmed guidance [4]. - The company also provided weaker-than-expected revenue guidance for 2026, attributing this to slower production progress and increased execution risks [4]. Stock Market Reaction - Following the announcement of its financial results, Eos's stock price dropped over 39% on February 26, 2026 [5][9].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [4]. - Investors have until March 9, 2026, to request to be appointed as lead plaintiffs in the case [4][9]. - The lawsuit claims violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [4]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its accounts receivable collection practices, claiming to rely on "detailed reviews of historical collections," while actually using a 180-day cliff method for reserving uncollectable accounts [5]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses [5]. Group 3: Stock Performance Impact - On November 12, 2025, Ardent Health announced a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 on November 13, 2025 [6][9].

Group 1 - Select Medical Holdings Corporation is being investigated for its sale to a consortium led by its executives and directors for $16.50 in cash per share [1] - The investigation focuses on whether Select Medical and its board violated federal securities laws and fiduciary duties by not obtaining the best price, failing to conduct a fair sales process, and not disclosing all material information [2] - Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief for shareholders [3]

APO Investors Have Opportunity to Lead Apollo Global Management, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm [Accessibility Statement] Skip NavigationNEW YORK, March 2, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Apollo Global Management, Inc. (NYSE: APO) between May 10, 2021 and February 21, 2026, both dates inclusive (the "Class Period"). A class action lawsuit has already b ...

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Eos Energy Enterprises, Inc. ("Eos†or the "Company†) (NASDAQ:EOSE). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. [LEARN MORE ABOUT THE INVESTIGATION] What Happened? On February 26, 2026, Eos reported a substantial net loss of approximately $970 million for fis. ...

Core Viewpoint - A class action securities lawsuit has been filed against NuScale Power Corporation, alleging securities fraud that affected investors between May 13, 2025, and November 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that ENTRA1 Energy LLC had no significant experience in building, financing, or operating projects in nuclear power generation, which was concealed from investors [2]. - It is alleged that NuScale entrusted its commercialization and deployment of its Power Modules to ENTRA1, despite its lack of relevant experience, exposing the company to undisclosed risks [2]. - The complaint also states that the qualifications attributed to ENTRA1 were actually related to the Habboush Group, which also lacks significant experience in nuclear power generation [2]. Group 2: Investor Information - Investors who suffered losses during the specified period have until April 20, 2026, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate in the lawsuit [3]. Group 3: Law Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]. - The firm has over 70 employees dedicated to serving clients in complex securities litigation [4].

NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: KD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kyndryl investors who were adversely affected by alleged securities fraud between August 7, 2024 and February 9, 2026. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/kyndryl-holdings-lawsuit ...

Core Viewpoint - A class action securities lawsuit has been filed against Picard Medical, Inc. for alleged securities fraud affecting investors between September 2, 2025, and October 31, 2025 [1][2]. Group 1: Allegations - The lawsuit claims that Picard Medical was involved in a fraudulent stock promotion scheme that utilized social media misinformation and impersonated financial professionals [2]. - It is alleged that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign [2]. - The company's public statements and risk disclosures reportedly omitted any mention of false rumors and artificial trading activity that influenced the stock price [2]. - As a result of these actions, the defendants' positive statements regarding the company's business, operations, and prospects were deemed materially misleading and lacked a reasonable basis [2]. Group 2: Legal Process - Investors who suffered losses in Picard Medical, Inc. during the specified timeframe have until April 3, 2026, to request appointment as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Law Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has a strong track record in high-stakes securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ardent Health, Inc. ("Ardent Health, Inc." or the "Company") (NYSE: ARDT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Ardent Health, Inc. investors who were adversely affected by alleged securities fraud between July 18, 2024 and November 12, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/a ...

Core Viewpoint - A class action securities lawsuit has been filed against Bath & Body Works, Inc. alleging securities fraud that affected investors between June 4, 2024, and November 9, 2025 [1] Group 1: Allegations of Fraud - The lawsuit claims that the company's strategy of pursuing "adjacencies, collaborations and promotions" failed to grow the customer base and did not deliver the expected growth in net sales [2] - It is alleged that as the company's strategy faltered, it relied on brand collaborations to mask weak financial results [2] - The complaint states that the company was unlikely to meet its previously issued financial guidance due to these issues [2] - Positive statements made by the defendants regarding the company's business and prospects were misleading and lacked a reasonable basis [2] Group 2: Legal Process and Participation - Investors who suffered losses during the specified time frame have until March 13, 2026, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securing compensation for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]